Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Eye Movement Testing and Therapy
This study has been completed.
Study NCT00472485   Information provided by Ohio State University
First Received: May 9, 2007   Last Updated: July 1, 2008   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

May 9, 2007
July 1, 2008
 
 
 
Complete list of historical versions of study NCT00472485 on ClinicalTrials.gov Archive Site
 
 
 
Study of Eye Movement Testing and Therapy
 

The purpose of this study is to determine the ability of several eye movement monitors, used in clinical practice, to identify children with poor reading eye movements. A second purpose of the study is to evaluate the effectiveness of eye movement therapy.

 
 
Interventional
Treatment, Non-Randomized, Open Label, Historical Control, Crossover Assignment
  • Saccadic Eye Movement Deficiency
  • Oculomotor Deficiency
  • Oculomotor Dysfunction
Procedure: eye movement therapy
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
40
 
 

Inclusion Criteria:

  • Children ages 8 to 13 with saccadic eye movement deficit

Exclusion Criteria:

  • Previous saccadic eye movement therapy
Both
8 Years to 13 Years
Yes
 
United States
 
 
NCT00472485
 
 
Ohio State University
 
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
Ohio State University
July 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.